BREAKING NEWS AT PRESS
The European Patent Office (EPO) has awarded Biomax a contract to deliver a Biological Sequence Query System to the EPO as a service.
DOWNLOAD BROCHURE
Patient Stratification
Treat the Individual with the Knowledge of All
EDUCATION
PART II:SEMANTIC DATA INTEGRATION PROVIDES THE FOUNDATION FOR PERSONALIZED MEDICINE
Given the highly heterogeneous nature of the composite data needed for the successful implementation of personalized medicine (PM) approaches, it becomes clear that only semantic integration offers a viable strategy. Semantic integration is the only approach enabling patient-centric data annotation and analysis required by PM. Read more.
IMPROVEMENTS IN CLINICAL RECORDS MAINTENANCE REQUIRES NEW THINKING
Dr. Klaus Heumann, explains why “successful next-generation health informatics will resemble an ecosystem that evolves by continuous adaptation.” See the full explanation in the article, “A Matter of Balance,” published in Public Service Review: Health and Social Care, Issue 35, 2013. Share your comments with us at health@biomax.com. Read more.
APPLICATIONS
VISCOVERY® PROVIDES GROUND-BREAKING ANALYSIS OF MULTIPLE COMORBIDITIES IN COPD
Click to enlarge
A recent paper on the co-occurrence of clinically important comorbidities and the prevalence of multimorbidity in the pathophysiology of COPD demonstrates the strengths of The Viscovery® Profiler in the life sciences. The Viscovery Profiler identified comorbidity clusters in a data set of COPD patients and characterized them in terms of health status, clinical outcomes and systemic inflammation. Read the results in the American Journal of Respiratory and Critical Care Medicine.
Click for the abstract.
NEWS
DR. MARTIJN SPRUIT TALKS ABOUT SEMANTIC DATA INTEGRATION AT HC2013, UK
Biomax would like to thank Dr. Martijn Spruit for speaking at the HC2013 conference last month in Birmingham. His talk, “Semantic Data Integration Delivers Comprehensive Personalized Medicine” provided several insights into how a health informatics project transformed the overwhelming task of integrating volumes of heterogeneous data into a manageable and productive task. Dr. Spruit is the Scientific Advisor and Leader of Physical Activity, Exercise Training and Rehabitation at CIRO, The Netherlands. See the presentation here.
VISCOVERY® SOFTWARE SUITE V6.0 INCLUDES NEW FEATURES FOR LIFE SCIENCE RESEARCH

Click for Press Release
Biomax's data-mining subsidiary in Vienna has launched the latest major release of the Viscovery® Software Suite, which enables users to uncover high-value insights from complex data sets. Building on Viscovery's unique, patented technology for explorative analysis and statistical modeling of complex data, several new features emerged from projects in the life science sector. Learn more about Viscovery in the life sciences here.
SUBSCRIBE TO THE BIOMAX NEWS FEED
Stay informed on Biomax and industry news and breakthroughs – join the Biomax news feed today. You can subscribe to this feed to receive updates when this content changes. Register here.
ADS
DISCOVER THE ONLINE PEDANT SEQUENCE ANALYSIS SOFTWARE AND BE AMAZED
Click for more information This is the easiest and most reliable sequence analysis tools for microbial genome-wide gene analysis and discovery anywhere. Contact Biomax for more information. Read more.
 
Biomax Informatics AG  
Robert-Koch-Str.2
D-82152 Planegg,
Germany
 

      UNSUBSCRIBE


Phone:  +49 89 895574-0
Email: info@biomax.com
Website: www.biomax.com

Biomax, BioXM, Pedant-Pro and PEDANT are registered trademarks of Biomax Informatics AG in Germany and other countries. Viscovery is a registered trademark of Viscovery Software GmbH. Registered trademarks used in this document or attachments, even when not specifically marked as such, are not to be considered unprotected by law.